TAG 08-02 is a prospective, multicenter, single-arm study to evaluate the use of the CTAG Device in traumatic transection of the descending thoracic aorta.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
51
Endovascular stent graft
Unnamed facility
Los Angeles, California, United States
Unnamed facility
Stanford, California, United States
All Cause Mortality
Time frame: 30 days post-treatment
Major Device Events
Major device events requiring reintervention through 1 month study window. Possible device events include but are not limited to endoleak, migration, wire fracture, compression, erosion, extrusion, aortic dilatation, endograft infection, and aortic rupture.
Time frame: 1 month post-treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Jacksonville, Florida, United States
Unnamed facility
Tampa, Florida, United States
Unnamed facility
Baltimore, Maryland, United States
Unnamed facility
Boston, Massachusetts, United States
Unnamed facility
Ann Arbor, Michigan, United States
Unnamed facility
Minneapolis, Minnesota, United States
Unnamed facility
St Louis, Missouri, United States
Unnamed facility
Omaha, Nebraska, United States
...and 16 more locations